Cytotoxic T cells overcome BCR-ABL-mediated resistance to apoptosis

Research output: Contribution to journalArticle

Abstract

Chronic myeloid leukemia is a disease marked by expanded clonal hematopoiesis; it is incurable by chemotherapy or radiation but is cured in a majority of patients receiving bone marrow transplantation from nonidentical sibling donors, an outcome generally attributed to a T cell-mediated graft- versus-leukemia effect. In this report, we examine the effect of the P210(BCR-ABL) fusion protein of the BCR-ABL oncogene, the molecular hallmark of chronic myelogenous leukemia, on the sensitivity of mouse cell lines to apoptosis induced by chemotherapy, radiation, or activated cytotoxic T lymphocytes (CTLs). We find that, although cells expressing P210(BCR-ABL) by gene transfer are more resistant than their normal counterparts to apoptosis induced by chemotherapy or radiation, they are equally susceptible to apoptosis induced by alloreactive CTLs. These results show that CTLs overcome BCR-ABL-mediated resistance to apoptosis and, therefore, provide a biological correlation for the success of allogeneic bone marrow transplantation in chronic myelogenous leukemia.

Original languageEnglish (US)
Pages (from-to)463-466
Number of pages4
JournalCancer Research
Volume55
Issue number3
StatePublished - 1995

Fingerprint

Cytotoxic T-Lymphocytes
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Apoptosis
T-Lymphocytes
Radiation
Bone Marrow Transplantation
Drug Therapy
Homologous Transplantation
Hematopoiesis
Oncogenes
Siblings
Leukemia
Tissue Donors
Transplants
Cell Line
Genes
Proteins

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Cytotoxic T cells overcome BCR-ABL-mediated resistance to apoptosis. / Fuchs, Ephraim J; Bedi, Atul; Jones, Richard J; Hess, A. D.

In: Cancer Research, Vol. 55, No. 3, 1995, p. 463-466.

Research output: Contribution to journalArticle

@article{59e4c5401a3d49929b3a2e469cb97f49,
title = "Cytotoxic T cells overcome BCR-ABL-mediated resistance to apoptosis",
abstract = "Chronic myeloid leukemia is a disease marked by expanded clonal hematopoiesis; it is incurable by chemotherapy or radiation but is cured in a majority of patients receiving bone marrow transplantation from nonidentical sibling donors, an outcome generally attributed to a T cell-mediated graft- versus-leukemia effect. In this report, we examine the effect of the P210(BCR-ABL) fusion protein of the BCR-ABL oncogene, the molecular hallmark of chronic myelogenous leukemia, on the sensitivity of mouse cell lines to apoptosis induced by chemotherapy, radiation, or activated cytotoxic T lymphocytes (CTLs). We find that, although cells expressing P210(BCR-ABL) by gene transfer are more resistant than their normal counterparts to apoptosis induced by chemotherapy or radiation, they are equally susceptible to apoptosis induced by alloreactive CTLs. These results show that CTLs overcome BCR-ABL-mediated resistance to apoptosis and, therefore, provide a biological correlation for the success of allogeneic bone marrow transplantation in chronic myelogenous leukemia.",
author = "Fuchs, {Ephraim J} and Atul Bedi and Jones, {Richard J} and Hess, {A. D.}",
year = "1995",
language = "English (US)",
volume = "55",
pages = "463--466",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "3",

}

TY - JOUR

T1 - Cytotoxic T cells overcome BCR-ABL-mediated resistance to apoptosis

AU - Fuchs, Ephraim J

AU - Bedi, Atul

AU - Jones, Richard J

AU - Hess, A. D.

PY - 1995

Y1 - 1995

N2 - Chronic myeloid leukemia is a disease marked by expanded clonal hematopoiesis; it is incurable by chemotherapy or radiation but is cured in a majority of patients receiving bone marrow transplantation from nonidentical sibling donors, an outcome generally attributed to a T cell-mediated graft- versus-leukemia effect. In this report, we examine the effect of the P210(BCR-ABL) fusion protein of the BCR-ABL oncogene, the molecular hallmark of chronic myelogenous leukemia, on the sensitivity of mouse cell lines to apoptosis induced by chemotherapy, radiation, or activated cytotoxic T lymphocytes (CTLs). We find that, although cells expressing P210(BCR-ABL) by gene transfer are more resistant than their normal counterparts to apoptosis induced by chemotherapy or radiation, they are equally susceptible to apoptosis induced by alloreactive CTLs. These results show that CTLs overcome BCR-ABL-mediated resistance to apoptosis and, therefore, provide a biological correlation for the success of allogeneic bone marrow transplantation in chronic myelogenous leukemia.

AB - Chronic myeloid leukemia is a disease marked by expanded clonal hematopoiesis; it is incurable by chemotherapy or radiation but is cured in a majority of patients receiving bone marrow transplantation from nonidentical sibling donors, an outcome generally attributed to a T cell-mediated graft- versus-leukemia effect. In this report, we examine the effect of the P210(BCR-ABL) fusion protein of the BCR-ABL oncogene, the molecular hallmark of chronic myelogenous leukemia, on the sensitivity of mouse cell lines to apoptosis induced by chemotherapy, radiation, or activated cytotoxic T lymphocytes (CTLs). We find that, although cells expressing P210(BCR-ABL) by gene transfer are more resistant than their normal counterparts to apoptosis induced by chemotherapy or radiation, they are equally susceptible to apoptosis induced by alloreactive CTLs. These results show that CTLs overcome BCR-ABL-mediated resistance to apoptosis and, therefore, provide a biological correlation for the success of allogeneic bone marrow transplantation in chronic myelogenous leukemia.

UR - http://www.scopus.com/inward/record.url?scp=0028961520&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028961520&partnerID=8YFLogxK

M3 - Article

C2 - 7834607

AN - SCOPUS:0028961520

VL - 55

SP - 463

EP - 466

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 3

ER -